Cimed provides double your billing until 2020 with entry into new sector

The pharmacist Cimed ends 2017 providing double your billing until 2020, after ending this year with revenues of $1 billion, high R of 28% compared to last year. One of the strategies to achieve the goal is the entry into a new segment, the dermocosmetics, starting next year.
To sustain growth, Cimed already took the role to build a new factory of solid drugs in Pouso Alegre, Minas Gerais, with investments of R $100 million. Another important contribution will be in the production line of dietary supplements and multivitamins, especially Lavitan, vitamins.